close
wild yam

Wild yam

Wild yam (Dioscorea villosa L.) root extract is a medicinal herb that is commonly used to treat hot flushes symptoms of menopause, premenstrual syndrome, osteoporosis, prophylactic against breast cancer and rheumatoid arthritis. Wild yam is most commonly used as a “natural alterative” to estrogen therapy for symptoms of menopause, infertility, menstrual problems, and other conditions, but there is no good scientific evidence to support these or other uses 1. Wild yam root and the bulb contains a chemical called diosgenin, which is prepared as an “extract,” a liquid that contains concentrated diosgenin. This chemical can be converted in the laboratory into various steroids, such as estrogen and dehydroepiandrosterone (DHEA). However, while wild yam does seem to have some estrogen-like activity, it is not actually converted into estrogen in the body, because humans cannot convert diosgenin into progesterone, so eating or applying wild yam extract or diosgenin does not result in increased progesterone levels 2. It takes a laboratory to do that. Sometimes wild yam and diosgenin are promoted as a “natural DHEA.” This is because in the laboratory DHEA is made from diosgenin. But this chemical reaction is not believed to occur in the human body. So, taking wild yam extract will not increase DHEA levels in people.

Wild yams also make a significant contribution both as root crops and vegetables to the diets of tribal people in the world especially in the tropics and sub tropics 3. Furthermore wild yam roots were found to be fairly good sources of dietary minerals such as calcium (18.08–74.79 mg/100 g), iron (11.15–28.61 mg/100 g), zinc (2.11–6.21 mg/100 g) and phosphorous (179–248 mg/100 g) with the levels of heavy metal concentrations that are lower than the recommended tolerable levels proposed by World Health Organization (WHO) Expert Committee on Food Additives 4. The heavy metals concentration (mg/100 g) ranged from: cobalt (1.06–1.98 mg/100 g), nickel (0.30–0.89 mg/100 g), chromium (2.10–4.53 mg/100 g) and lead (0.11–0.93 mg/100 g) among the studied yam species 4.

Vasomotor symptoms (e.g, hot flashes and night sweats) are the primary symptoms of menopause. Vasomotor symptoms affect more than 80% of women in menopause and are the menopause symptoms for which most women seek treatment 5.

Nonhormonal agents used as therapy for hot flushes (hot flashes) in menopause 6:

  • Nonprescription
    • Black cohosh
    • Dong quai
    • Evening primrose oil
    • Ginseng
    • Melatonin
    • Red clover isoflavones
    • Soy isoflavones
    • Vitamin E
    • Wild yam
  • Prescription
    • Belladonna/ergotamine tartrate/phenobarbital combination (Bellamine)
    • Clonidine (Catapres)
    • Fluoxetine (Prozac)
    • Gabapentin (Neurontin)
    • Mirtazapine (Remeron)
    • Paroxetine (Paxil)
    • Trazodone (Desyrel)
    • Venlafaxine (Effexor)

Existing research indicates that mind-body interventions such as relaxation, mindfulness, and cognitive behavioral therapy (CBT) can reduce stress and bothersomeness associated with menopausal symptoms 7. Hypnosis intervention for hot flashes has been shown to result in a clinically significant reduction (ie, 50% or more) in hot flashes and associated symptoms. Mind-body interventions have few negative side effects and seem to provide safe treatment options worthy of consideration 7.

Hypnosis

Hypnosis, a mind-body therapy that involves a deeply relaxed state of focused attention, individualized mental imagery, and suggestion 8, has been investigated for menopausal symptom management. Two randomized clinical trials of 5 sessions of hypnotherapy for hot flashes among breast cancer survivors demonstrated a clinically meaningful (≥69%) reduction in hot flash severity and frequency 9, 10. These results are comparable to pharmacological interventions 11. In an randomized controlled trial of 187 women 12, hypnosis was compared with an active structured attention control and found to significantly reduce subjective hot flash frequency (74%) and interference (80%), and physiologically monitored hot flashes (57%). In addition, hypnosis improved self-reported sleep quality and sexual function 13. In a 2017 pilot study 14, 71 women were randomized to 1 of 4 groups: venlafaxine 75 mg + hypnosis, venlafaxine 75 mg + sham hypnosis, placebo pill + hypnosis, and placebo pill + sham hypnosis. Hypnosis alone was as effective (50% reduction) as venlafaxine 75 mg alone in reducing hot flash score (frequency × severity). The placebo group reported a 25% reduction. Hypnosis has been recommended by the North American Menopause Society, and others, for the treatment of menopausal symptoms and poses little risk 15.

Cognitive behavioral therapy (CBT)

Cognitive behavioral therapy (CBT) is a form of psychological treatment that has been used to treat hot flashes, depression, and other menopausal symptoms. Cognitive behavioral therapy (CBT) is a time-limited treatment that focuses on changing cognitive appraisals and behavior choices to alter symptoms. Cognitive behavioral therapy (CBT) may include education, motivational interviewing, relaxation, paced breathing, and other strategies to improve symptoms 16. Mann et al 16 compared the effects of a 6-week cognitive behavioral therapy (CBT) intervention to usual care (eg, standard follow-up care) among 96 female breast cancer survivors and found hot flash interference was reduced on average 52%. Women receiving usual care reported a 25% decrease in hot flash interference. Hot flash frequency was reduced by 38% in both groups, 38% indicating cognitive behavioral therapy (CBT) was no better than usual care for reducing the frequency of hot flashes 16. In a second randomized controlled trial, 65% of women receiving a 4-week cognitive behavioral therapy (CBT) intervention and 21% of a no-treatment control group, reported clinically significant improvements (eg, 2-point change on a 10-point numerical rating scale) in hot flush interference 17. Cognitive behavioral therapy (CBT) did not demonstrate a clinically significant reduction (eg, 50%) in hot flash frequency 17. Both of these trials used objective and subjective measures for hot flash frequency 16

In a pilot study of 39 women randomized to cognitive behavioral therapy (CBT) or waitlist control, there was a statistically significant reduction in hot flash distress, but not in interference or frequency of hot flashes/night sweats, in the immediate treatment group 18. The authors reported a 48% positive treatment effect for the 17 women who completed the cognitive behavioral therapy (CBT) program, but it is unclear how that effect was calculated 18. In addition, there is some evidence to suggest that cognitive behavioral therapy (CBT) may reduce mild depression in menopause comparable to placebo 19. To date, no randomized controlled trials of cognitive behavioral therapy (CBT) have demonstrated clinically significant improvements in hot flash frequency, but may be beneficial in reducing hot flash distress and interference and other psychological symptoms (eg, depression) associated with menopause. cognitive behavioral therapy (CBT) has been recommended by the North American Menopausal Society for reducing the bothersomeness of vasomotor symptoms, but not for frequency 20.

Wild yam benefits

Wild yam is a tuber that has been historically used in traditional Chinese medicine to treat multiple symptoms, including symptoms of menopause 21. However, there is limited and inconsistent evidence for the effects of wild yam on menopause symptoms 7. In a double blind, placebo controlled, cross-over study of the effects of a wild yam cream for 3 months in 23 healthy women suffering from troublesome symptoms of the menopause such as hot flashes and night sweats 22. After 3 months treatment with topical wild yam extract in women suffering from menopausal symptoms it was found that the wild yam cream is free from side-effects and has little effect on menopausal symptoms 22. Wild yam cream was no better than placebo in reducing menopause symptoms or improving levels of estrogen or progesterone 22. In contrast, a randomized controlled trial of 50 women consuming 12 mg of purple yam (Dioscorea alata) extract twice daily for 12 months reported significant improvements (90%) in menopause symptoms (primarily psychological) compared with the placebo group (70%) as measured by the Greene Climacteric Scale 23. The authors note that sexual functioning symptoms did not show the same levels of improvement 23. Because of the small number of studies and insufficient information regarding long-term safety, more research is needed in order to determine the efficacy of wild yam for menopause symptoms 1.

There is insufficient evidence to rate effectiveness of wild yam extract for:

  • Memory and thinking skills (cognitive function). Early research shows that taking wild yam extract daily for 12 weeks might improve thinking skills in healthy adults.
  • Use as a natural alternative to estrogens.
  • Postmenopausal vaginal dryness.
  • Premenstrual syndrome (PMS).
  • Weak and brittle bones (osteoporosis).
  • Increasing energy and sexual desire in men and women.
  • Gallbladder problems.
  • Increasing appetite.
  • Diarrhea.
  • Menstrual cramps (dysmenorrhea).
  • Rheumatoid arthritis (RA).
  • Infertility.
  • Menstrual disorders.
  • Other conditions.

Wild yam dosage

The appropriate dose of wild yam depends on several factors such as your age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for wild yam. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

Wild yam side effects

When taken by mouth, wild yam is POSSIBLY SAFE. Large amounts may cause vomiting, upset stomach, and headache.

When applied to the skin, wild yam is POSSIBLY SAFE.

Special precautions and warnings

There was an increase in fibrosis in the kidneys and in inflammation in livers of rats consuming wild yam (dioscorea villosa) for 28 days 1. Long term supplementation with wild yam (dioscorea villosa) may be best avoided, especially in people with compromised renal function and in those who need to take other drugs which may alter kidney function 1.

  • Pregnancy and breast-feeding: There isn’t enough reliable information to know if wild yam is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.
  • Hormone-sensitive condition such as breast cancer, uterine cancer, ovarian cancer, endometriosis, or uterine fibroids: Wild yam might act like estrogen. If you have any condition that might be made worse by exposure to estrogen, do not use wild yam.
  • Protein S deficiency: People with protein S deficiency have an increased risk of forming clots. There is some concern that wild yam might increase the risk of clot formation in these people because it might act like estrogen. One patient with protein S deficiency and systemic lupus erythematosus (SLE) developed a clot in the vein serving the retina in her eye 3 days after taking a combination product containing wild yam, dong quai, red clover, and black cohosh. If you have protein S deficiency, it is best to avoid using wild yam until more is known.

Interactions with medications

Be cautious when using wild yam extract with this combination.

Estrogens

  • Wild yam might have some of the same effects as estrogen. Taking wild yam along with estrogen pills might decrease the effects of estrogen pills.
  • Some estrogen pills include conjugated equine estrogens (Premarin), ethinyl estradiol, estradiol, and others.
References
  1. Wojcikowski K, Wohlmuth H, Johnson DW, Gobe G. Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways. Food Chem Toxicol. 2008 Sep;46(9):3122-31. https://doi.org/10.1016/j.fct.2008.06.090
  2. Fugh-Berman A. Progesterone cream for osteoporosis. Alternative Therapies Women’s Health. 1999;1(5):33–40.
  3. Ngo Ngwe MF, Omokolo DN, Joly S. Evolution and Phylogenetic Diversity of Yam Species (Dioscorea spp.): Implication for Conservation and Agricultural Practices. PLoS One. 2015 Dec 21;10(12):e0145364. doi: 10.1371/journal.pone.0145364
  4. Padhan, B., Biswas, M., Dhal, N. K., & Panda, D. (2018). Evaluation of mineral bioavailability and heavy metal content in indigenous food plant wild yams (Dioscorea spp.) from Koraput, India. Journal of food science and technology, 55(11), 4681–4686. https://doi.org/10.1007/s13197-018-3388-3
  5. Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women’s Health across the Nation. Obstet Gynecol Clin North Am. 2011 Sep;38(3):489-501. doi: 10.1016/j.ogc.2011.05.006
  6. Nonhormonal Therapies for Hot Flashes in Menopause. Am Fam Physician. 2006 Feb 1;73(3):457-464. https://www.aafp.org/afp/2006/0201/p457.html
  7. Johnson, A., Roberts, L., & Elkins, G. (2019). Complementary and Alternative Medicine for Menopause. Journal of evidence-based integrative medicine, 24, 2515690X19829380. https://doi.org/10.1177/2515690X19829380
  8. Ruysschaert N. Relief from hot flashes. The natural, drug-free program to reduce hot flashes, improve sleep, and ease stress, by Gary Elkins. Am J Clin Hypn. 2016 Jan;58(3):323-5. doi: 10.1080/00029157.2016.1104998
  9. Elkins G, Marcus J, Stearns V, Hasan Rajab M. Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors. Psychooncology. 2007 May;16(5):487-92. doi: 10.1002/pon.1096
  10. Elkins G, Marcus J, Stearns V, Perfect M, Rajab MH, Ruud C, Palamara L, Keith T. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol. 2008 Nov 1;26(31):5022-6. doi: 10.1200/JCO.2008.16.6389
  11. Fisher WI, Johnson AK, Elkins GR, Otte JL, Burns DS, Yu M, Carpenter JS. Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA Cancer J Clin. 2013 May;63(3):167-92. doi: 10.3322/caac.21171
  12. Elkins GR, Fisher WI, Johnson AK, Carpenter JS, Keith TZ. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause. 2013 Mar;20(3):291-8. doi: 10.1097/gme.0b013e31826ce3ed
  13. Johnson AK, Johnson AJ, Barton D, Elkins G. Hypnotic Relaxation Therapy and Sexual Function in PostmenopausalWomen: Results of a Randomized Clinical Trial. Int J Clin Exp Hypn. 2016;64(2):213-24. doi: 10.1080/00207144.2016.1131590
  14. Barton DL, Schroeder KCF, Banerjee T, Wolf S, Keith TZ, Elkins G. Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study. Menopause. 2017 Jul;24(7):774-782. doi: 10.1097/GME.0000000000000837
  15. Goldstein KM, Shepherd-Banigan M, Coeytaux RR, McDuffie JR, Adam S, Befus D, Goode AP, Kosinski AS, Masilamani V, Williams JW Jr. Use of mindfulness, meditation and relaxation to treat vasomotor symptoms. Climacteric. 2017 Apr;20(2):178-182. doi: 10.1080/13697137.2017.1283685
  16. Mann E, Smith MJ, Hellier J, Balabanovic JA, Hamed H, Grunfeld EA, Hunter MS. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012 Mar;13(3):309-18. doi: 10.1016/S1470-2045(11)70364-3
  17. Ayers B, Smith M, Hellier J, Mann E, Hunter MS. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause. 2012 Jul;19(7):749-59. doi: 10.1097/gme.0b013e31823fe835
  18. Keefer L, Blanchard EB. A behavioral group treatment program for menopausal hot flashes: results of a pilot study. Appl Psychophysiol Biofeedback. 2005 Mar;30(1):21-30. doi: 10.1007/s10484-005-2171-1
  19. Khoshbooii R, Hassan SA, Hamzah MSG, Baba MB. Effectiveness of group cognitive behavioral therapy on depression among Iranian women around menopause. Aust J Basic Appl Sci. 2011;5:991–995.
  20. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015 Nov;22(11):1155-72; quiz 1173-4. doi: 10.1097/GME.0000000000000546
  21. Liu SY, Wang JY, Shyu YT, Song LM. Studies on yams (Diascorea spp.) in Taiwan. J Chin Med. 1995;6:111–126.
  22. Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric. 2001 Jun;4(2):144-50.
  23. Hsu CC, Kuo HC, Chang SY, Wu TC, Huang KE. The assessment of efficacy of Diascorea alata for menopausal symptom treatment in Taiwanese women. Climacteric. 2011 Feb;14(1):132-9. doi: 10.3109/13697137.2010.498594
Health Jade Team

The author Health Jade Team

Health Jade